Q32 Bio Inc. Increase (Decrease) in Deferred Revenue
Q32 Bio Inc. (QTTB) reported Increase (Decrease) in Deferred Revenue of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2025-03-11
- Q32 Bio Inc. increase (decrease) in deferred revenue for the quarter ending 2024-12-31 was $0.00.
- Q32 Bio Inc. increase (decrease) in deferred revenue for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Q32 Bio Inc. increase (decrease) in deferred revenue for the quarter ending 2024-06-30 was $0.00.
- Q32 Bio Inc. increase (decrease) in deferred revenue for the quarter ending 2024-03-31 was $0.00.
- Q32 Bio Inc. increase (decrease) in deferred revenue for fiscal 2024 was $0.00.
- Q32 Bio Inc. increase (decrease) in deferred revenue for fiscal 2023 was -$25.85M.
- Q32 Bio Inc. increase (decrease) in deferred revenue for fiscal 2018 was -$252.00K, a 100.75% decline from fiscal 2017.
- Q32 Bio Inc. increase (decrease) in deferred revenue for fiscal 2017 was $33.41M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | $0.00 derived: sum of 3 quarters · filed 2025-03-11 | $0.00 10-K · filed 2025-03-11 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | -$40.34M derived: sum of 4 quarters · filed 2025-03-11 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | -$40.34M derived: sum of 3 quarters · filed 2025-03-11 | -$19.70M derived: sum of 4 quarters · filed 2025-03-11 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | -$40.34M derived: sum of 2 quarters · filed 2025-03-11 | -$19.70M derived: sum of 3 quarters · filed 2025-03-11 | -$22.90M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-12-31 | -$40.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$19.70M derived: sum of 2 quarters · filed 2025-03-11 | -$22.90M derived: sum of 3 quarters · filed 2025-03-11 | -$25.85M 10-K · filed 2025-03-11 |
| 2023-09-30 | $20.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $17.43M derived: sum of 2 quarters · filed 2024-11-07 | $14.49M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$3.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$6.15M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$2.95M 10-Q · filed 2024-05-09 | |||
| 2018-12-31 | -$190.69K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$88.53K derived: sum of 2 quarters · filed 2019-03-12 | -$95.38K derived: sum of 3 quarters · filed 2019-03-12 | -$252.00K 10-K · filed 2019-03-12 |
| 2018-09-30 | $102.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $95.32K derived: sum of 2 quarters · filed 2018-11-13 | -$61.30K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | -$6.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$163.47K 10-Q · filed 2018-08-13 | ||
| 2018-03-31 | -$156.62K 10-Q · filed 2018-05-14 | |||
| 2017-12-31 | $33.41M 10-K · filed 2019-03-12 |